These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33593238)

  • 21. Prevalence and Sociodemographic Correlates of Adolescent Use and Polyuse of Combustible, Vaporized, and Edible Cannabis Products.
    Peters EN; Bae D; Barrington-Trimis JL; Jarvis BP; Leventhal AM
    JAMA Netw Open; 2018 Sep; 1(5):e182765. PubMed ID: 30646180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods to Assess Cannabis Consumption in Population Surveys: Results of Cognitive Interviewing.
    Goodman S; Leos-Toro C; Hammond D
    Qual Health Res; 2019 Aug; 29(10):1474-1482. PubMed ID: 30600773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Legalization on Cannabis Use, Attitudes, and Purchasing Preferences: A Repeated Cross-Sectional Survey of Canadian Young Adults.
    Bradley AHM; Salmon M; Wohl MJA; Howard AL
    Cannabis; 2024; 7(2):65-76. PubMed ID: 38975596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.
    Pacula RL; Jacobson M; Maksabedian EJ
    Addiction; 2016 Jun; 111(6):973-80. PubMed ID: 26687431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.
    Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D
    Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and use of cannabis products and routes of administration among youth and young adults in Canada and the United States: A systematic review.
    Wadsworth E; Craft S; Calder R; Hammond D
    Addict Behav; 2022 Jun; 129():107258. PubMed ID: 35124565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Typical Hits, Grams, or Joints: Evaluating Cannabis Survey Measurement Strategies for Quantifying Consumption.
    Borodovsky JT; Hasin DS; Shmulewitz D; Walsh C; Livne O; Aharonovich E; Struble CA; Habib MI; Budney AJ
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):646-658. PubMed ID: 36577020
    [No Abstract]   [Full Text] [Related]  

  • 28. Price and product variation in Washington's recreational cannabis market.
    Davenport S
    Int J Drug Policy; 2021 May; 91():102547. PubMed ID: 31522966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status.
    Rup J; Freeman TP; Perlman C; Hammond D
    Addict Behav; 2021 Oct; 121():106991. PubMed ID: 34087766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in Quantity Measures of Various Forms of Cannabis Consumption among Emerging Adults in Canada in Relation to Policy and Public Health Developments.
    Yousufzai SJ; Cole AG; Nonoyama M; Barakat C
    Int J Environ Res Public Health; 2023 Jun; 20(13):. PubMed ID: 37444061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis labelling and consumer understanding of THC levels and serving sizes.
    Leos-Toro C; Fong GT; Meyer SB; Hammond D
    Drug Alcohol Depend; 2020 Mar; 208():107843. PubMed ID: 32044091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of trends in the prevalence of cannabis use and related metrics in Canada.
    Rotermann M
    Health Rep; 2019 Jun; 30(6):3-13. PubMed ID: 31216047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reasons for Purchasing Cannabis From Illegal Sources in Legal Markets: Findings Among Cannabis Consumers in Canada and U.S. States, 2019-2020.
    Goodman S; Wadsworth E; Hammond D
    J Stud Alcohol Drugs; 2022 May; 83(3):392-401. PubMed ID: 35590180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes.
    Karoly HC; Mueller RL; Andrade CC; Hutchison KE
    Front Psychiatry; 2020; 11():613243. PubMed ID: 33408657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing Blunt Smokers by Their Acquisition of Cannabis.
    Timberlake DS
    Subst Use Misuse; 2018 Jul; 53(9):1419-1423. PubMed ID: 29300122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Observational Method for Assessing Acute Responses to Cannabis: Preliminary Validation Using Legal Market Strains.
    Bidwell LC; Mueller R; YorkWilliams SL; Hagerty S; Bryan AD; Hutchison KE
    Cannabis Cannabinoid Res; 2018; 3(1):35-44. PubMed ID: 29607409
    [No Abstract]   [Full Text] [Related]  

  • 38. Cannabis edibles packaging: Communicative objects in a growing market.
    Ventresca M; Elliott C
    Int J Drug Policy; 2022 May; 103():103645. PubMed ID: 35276401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Adult E-Cigarette Users Vaporizing Cannabis Using E-Cigarettes and Vape-Pens.
    Morean ME; Lipshie N; Josephson M; Foster D
    Subst Use Misuse; 2017 Jul; 52(8):974-981. PubMed ID: 28323498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Price elasticity of illegal versus legal cannabis: a behavioral economic substitutability analysis.
    Amlung M; Reed DD; Morris V; Aston ER; Metrik J; MacKillop J
    Addiction; 2019 Jan; 114(1):112-118. PubMed ID: 30194789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.